Despite great promise, adoptive cell therapy (ACT) continues to fail at treating a majority of cancers, especially solid tumors. To inform development and expedite the translation of more potent cellular immunotherapies, advanced immunoimaging tools are needed to better understand the in vivo requirements for generating a robust immune response. Even methods to evaluate the delivery, location, and status of transferred T cells at the tumor target are lacking. Therefore, a real-time, safe, noninvasive, longitudinal imaging method is critically needed to 1) monitor adoptive T cell location and status and 2) assess treatment progression and response through imaging biomarkers. Here, we developed a combined ultrasound (US) and photoacoustic (PA) imaging approach to enable T cell tracking following adoptive transfer for cancer immunotherapy. Our approach leverages highly photostable gold nanorods and cell surface engineering to tag the T cells without impacting effector functions, as well as generate PA contrast for imaging post-transfer. Our in vivo US/PA imaging approach detected nanoparticle-labeled T cell accumulation at the tumor, visualized changes in tumor volume, and conveyed accompanying changes in blood biomarkers. US/PA data also showed different trends according to a positive or negative antitumor response to T cell therapy over 7 days. Results highlight the potential of the approach and motivate future development to expand the platform for advanced, theranostic immunoimaging.
Pulsed laser irradiation has emerged as an effective means to photothermally transform plasmonic nanostructures after their use in different biomedical applications. However, the ability to predict the products after photothermal transformation requires extensive ex situ studies. Here, we report a systematic study of the photothermal transformation of Au–Ag nanocages with a localized surface plasmon resonance at ca. 750 nm under pulsed laser irradiation at different fluences and a pulse duration of 5 ns. At biologically relevant laser energies, the pulsed laser transforms Au–Ag nanocages into pseudo-spherical, solid nanoparticles. The solid nanoparticles contained similar numbers of Au and Ag atoms to the parent Au–Ag nanocages. At increased laser fluences (>16 mJ cm−2) and number of pulses (>150), the average diameter of the resulting pseudo-spherical particles increased due to the involvement of Ostwald ripening and/or attachment-based growth. The changes in optical properties as a result of the transformation were validated using simulations based on the discrete dipole approximation method, where the spectral profiles and peak positions of the initial and final states matched well with the experimentally derived data. The results may have implications for the future use of Au–Ag nanocages in biomedicine, catalysis, and sensing.
Superparamagnetic nanoparticles have become an important tool in biomedicine. Their biocompatibility, controllable small size, and magnetic properties allow manipulation with an external magnetic field for a variety of diagnostic and therapeutic applications. Recently, the magnetically-induced motion of superparamagnetic nanoparticles has been investigated as a new source of imaging contrast. In magneto-motive imaging, an external, time-varying magnetic field is applied to move a magnetically labeled subject, such as labeled cells or tissue. Several major imaging modalities such as ultrasound, photoacoustic imaging, optical coherence tomography, and laser speckle tracking can utilize magneto-motive contrast to monitor biological events at smaller scales with enhanced contrast and sensitivity. In this review article, an overview of magneto-motive imaging techniques is presented, including synthesis of superparamagnetic nanoparticles, fundamental principles of magneto-motive force and its utility to excite labeled tissue within a viscoelastic medium, current capabilities of magneto-motive imaging modalities, and a discussion of the challenges and future outlook in the magneto-motive imaging domain.
In spite of great potential and substantial research, few stem cell therapies have reached clinical implementation. The lack of real-time longitudinal imaging feedback during procedures limits therapy development, making it challenging to evaluate outcomes from a research and clinical standpoint. In particular, stem cell therapies of the spinal cord could benefit from intra- and postoperative image guidance.1–5 In a recent clinical study, amyotrophic lateral sclerosis patients received stem cell treatments through direct injection into the spinal cord, which is appealing due to better outcomes in spite of high risk associated with the invasive surgical procedure.2,5–8 Real-time intraoperative image guidance of needle insertion is desired to improve procedure safety and guide stem cell delivery to the tissue target to validate success prior to completing the surgery.1,3,4 Next, postoperative monitoring is valuable to track stem cell location and function over time to evaluate therapy progression.
26 September 2020 in Ultrasound in Medicine & Biology
Photoacoustic imaging (PAI) is an emerging biomedical imaging modality with promise as a point-of-care diagnostic. This imaging modality relies on optical excitation of an absorber followed by production of ultrasound through the photoacoustic effect, resulting in high spatial resolution with imaging depths in the centimeter range. Herein, we disclose the discovery of the first benchmarking parameter for small molecule dye performance in PAI, which we term the acoustic loudness factor (ALF). ALF can predict dye performance in PAI without the need for access to photoacoustic instrumentation and can be used to guide the systematic evaluation of design strategies to enhance photoacoustic signal. Lastly, we demonstrate that enhancements in ALF can be translated to in vivo PAI. Akin to the use of fluorescence brightness in fluorophore design and evaluation for fluorescence imaging, we anticipate that ALF will guide the design and evaluation of improved probes for PAI.